BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24309020)

  • 21. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
    Shen K; Qi L; Stiff L
    Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
    Chen WL; Harris DL; Joyce NC
    Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LH/chorionic gonadotropin signaling pathway involves protein tyrosine phosphatase activity downstream of protein kinase A activation: evidence of an obligatory step in steroid production by Leydig cells.
    Cornejo Maciel F; Poderoso C; Gorostizaga A; Paz C; Podestá EJ
    J Endocrinol; 2001 Aug; 170(2):403-11. PubMed ID: 11479136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.
    Huang P; Ramphal J; Wei J; Liang C; Jallal B; McMahon G; Tang C
    Bioorg Med Chem; 2003 Apr; 11(8):1835-49. PubMed ID: 12659770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic studies on protein tyrosine phosphatases.
    Zhang ZY
    Prog Nucleic Acid Res Mol Biol; 2003; 73():171-220. PubMed ID: 12882518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin increases protein tyrosine phosphatase activity by a cAMP-dependent mechanism in rat adrenal gland.
    Paz C; Cornejo MacIel F; Mendez C; Podesta EJ
    Eur J Biochem; 1999 Nov; 265(3):911-8. PubMed ID: 10518784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
    Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
    Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
    Iversen LF; Andersen HS; Møller KB; Olsen OH; Peters GH; Branner S; Mortensen SB; Hansen TK; Lau J; Ge Y; Holsworth DD; Newman MJ; Hundahl Møller NP
    Biochemistry; 2001 Dec; 40(49):14812-20. PubMed ID: 11732900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
    Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
    J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of the protein tyrosine phosphatase superfamily.
    Wang WQ; Sun JP; Zhang ZY
    Curr Top Med Chem; 2003; 3(7):739-48. PubMed ID: 12678841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A general assay for monitoring the activities of protein tyrosine phosphatases in living eukaryotic cells.
    Harris LK; Frumm SM; Bishop AC
    Anal Biochem; 2013 Apr; 435(2):99-105. PubMed ID: 23333221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatase function: the substrate perspective.
    Tiganis T; Bennett AM
    Biochem J; 2007 Feb; 402(1):1-15. PubMed ID: 17238862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
    Zhang ZY
    Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases.
    Selner NG; Luechapanichkul R; Chen X; Neel BG; Zhang ZY; Knapp S; Bell CE; Pei D
    Biochemistry; 2014 Jan; 53(2):397-412. PubMed ID: 24359314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput screening of catalytically inactive mutants of protein tyrosine phosphatases (PTPs) in a phosphopeptide microarray.
    Sun H; Tan LP; Gao L; Yao SQ
    Chem Commun (Camb); 2009 Feb; (6):677-9. PubMed ID: 19322419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A general peptide substrate for protein tyrosine phosphatases.
    Daum G; Solca F; Diltz CD; Zhao Z; Cool DE; Fischer EH
    Anal Biochem; 1993 May; 211(1):50-4. PubMed ID: 8323038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
    Gao L; Sun H; Yao SQ
    Biopolymers; 2010; 94(6):810-9. PubMed ID: 20725946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.